Limestone Investment Advisors »

Aspire Biopharma Hldgs Inc Wt Exp 021430 shares owned by Limestone Investment Advisors

Quarter-by-quarter ownership of Aspire Biopharma Hldgs Inc Wt Exp 021430 (ASBPW) shares owned by Limestone Investment Advisors from 13F filings

Historical chart of Limestone Investment Advisors investment in Aspire Biopharma Hldgs Inc Wt Exp 021430

Tip: Access up to 7 years of quarterly data

All positions including Aspire Biopharma Hldgs Inc Wt Exp 021430 held by Limestone Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aspire Biopharma Hldgs Inc Wt Exp 021430 by Limestone Investment Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.2k 75k 0.03

More positions owned by Limestone Investment Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Apple Call Option (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Goldman Sachs Call Option (GS)
JPMorgan Chase & Co. Call Option (JPM)
Citigroup Com New Call Option (C)
Alphabet Cap Stk Cl A (GOOGL)
Asml Holding N V N Y Registry Shs Call Option (ASML)
Netflix (NFLX)
Wells Fargo & Company Call Option (WFC)
Bank of America Corporation Call Option (BAC)
Advanced Micro Devices (AMD)
Costco Wholesale Corporation (COST)

View all positions for Limestone Investment Advisors

Top funds holding Aspire Biopharma Hldgs Inc Wt Exp 021430

Adage Capital Partners GP
Saba Capital Management
Linden Advisors
Aristeia Capital
Highbridge Capital Management
Toronto-Dominion Bank
OZ Management
Verition Fund Management
Barclays
Clear Street
Millennium Management
Alberta Investment Management Corporation
Antara Capital
D. E. Shaw & Co
Wolverine Asset Management

View all funds holding Aspire Biopharma Hldgs Inc Wt Exp 021430